SEMA3E and Alzheimer disease: The strongest nominal MR result suggests that plasma Semaphorin 3E (SEMA3E) levels, as predicted by genotype, may be associated with AD progression (P = 6.5x10−4) and indicates that an increase in plasma SEMA3E levels associates with increased cognitive decline or more rapid AD progression (Fig 4).